General Methods and Materials

All reactions were carried out under an argon atmosphere and at room temperature (23 o C) unless the reaction was performed under aqueous conditions or unless otherwise specified.
Reactions undertaken at -78 o C utilized a bath of dry ice and acetone. Reactions carried out at 0 o C employed a bath of water and ice. Anhydrous THF, CH 2 Cl 2 , DMF, and MeCN were obtained using a PureSolv ® solvent purification system (water <10 ppm). Reactions were monitored by thin layer chromatography (TLC) on aluminium backed silica plates (Merck Silica Gel 60 F254). Visualisation of TLC plates was undertaken with an ultraviolet (UV) light at  = 254 nm and staining with solutions of vanillin or phosphomolybdic acid (PMA), followed by exposure of the stained plates to heat. Silica flash column chromatography (Silica Gel 60 40 -63 m) was undertaken to purify crude reaction mixtures using solvents as specified. Separations were performed using a Biotage Isolera ® purification system with a diode array detector and a fraction collector.
NMR spectra were obtained using a Bruker DRX 400 or DRX 500 at frequencies of 400 MHz or 500 MHz respectively in CDCl 3 , CD 3 OD, CD 3 CN, or DMSO-d 6 . Chemical shifts are reported in parts per million (ppm) and coupling constants in Hertz (Hz). The residual solvent peaks were used as internal standards (CDCl 3 : δ H = 7.26, δ C = 77.16; CD 3 OD: δ H = 3.31, δ C = 49.00; CD 3 CN: δ H = 1.94, δ C = 118.26/1.32; DMSO-d 6 : δ H = 2.50, δ C = 39.52 ppm). [1] . 1 H NMR data is reported as follows: Chemical shift values (ppm), multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling constant(s) and relative integral.
13
C NMR spectra were obtained using a Bruker DRX 300, DRX 400, or DRX 500 at 75.5
MHz, 100.6 MHz, or 125.8 MHz in CDCl 3 , CD 3 OD, CD 3 CN, or DMSO-d 6 .
C NMR data is reported as chemical shift values (ppm). In the case of diastereomeric mixtures, the signals of the major diastereomer are reported unless otherwise noted.
Mass spectra were recorded on a Shimadzu 2020 (ESI) mass spectrometer operating in positive mode. High resolution mass spectra were recorded on a Bruker-Daltronics Apex Ultra 7.0T Fourier transform (FTICR) mass spectrometer.
Optical rotations were measured on a Perkin-Elmer 341 polarimeter at a wavelenght of 589 nm. IR spectra were recorded on a Bruker ALPHA FT-IR-spectrometer using a diamond ATR unit.
Melting points were determined with a SRS Optimelt melting point apparatus and are uncorrected.
Preparative RP-HPLC was performed using a Waters 600 Multisolvent Delivery System and Waters 500 pump with 2996 photodiode array detector. Programmable wavelength detector operating at 210 -300 nm. Compounds were purified using a XBridge BEH C 18 5 μm or a Sunfire C 18 (19 × 150 mm or 30 × 150 mm) column operating at total flow rates of 32.0 mL·min LC/MS was performed on a Shimadzu UPLC/MS instrument consisting of a LC-M20A pump and a SPD-M30A diode array detector coupled to a Shimadzu 2020 mass spectrometer (ESI) operating in positive mode. Separations on the UPLC/MS system were performed using a Waters Acquity UPLC BEH C 18 1.7 µm column (2.1 × 50 mm at a total flow rate of 0.60 mL·min -1 . Separations were performed using a mobile phase of 0.1% formic acid in water (Solvent A) and 0.1% formic acid in acetonitrile (Solvent B). 
General Procedures
Fmoc-deprotection:
The resin was treated with 20% piperidine/DMF (2 × 1 mL, 3 min) and washed with DMF (5 × 1 mL), DCM (5 × 1 mL) and DMF (5 × 1 mL).
Capping: Acetic anhydride/pyridine (1:9 v/v, 1 mL)) was added to the resin. After 3 min the resin was washed with DMF (5 × 1 mL), DCM (5 × 1 mL) and DMF (5 × 1 mL). 
Experimental and analytical data (R)-Fmoc-N(Me)-Phg-OH (7)
A suspension of (R)-N-methylphenylglycine (495 mg, 3.00 mmol) and FmocOSu (1.11 g, 3.30 mmol) in THF/sat. NaHCO 3 (20 mL, 1:1, v/v) was stirred at rt for 15 h. The reaction mixture was diluted with H 2 O (10 mL), then washed with Et 2 O (25 mL). Subsequently, HCl (1M) was added dropwise to reach pH = 3. The reaction mixture was extracted with ethyl acetate (3 × 20 mL), the combined organic extracts were dried over anhydrous Na 2 SO 4 , and the solvent was removed in vacuo yielding 1.10 g (95%) of the Fmoc-protected amino acid 7 as a colorless solid. 4, 144.0, 143.9, 141.5, 129.2, 129 0, 128.8, 127.9, 127.2, 125.20, 125.16, 120.1, 68.2, 62.7, 47.4 
Alloc-Thr-OH
L-Threonine (5, 2.38 g, 20.0 mmol) was suspended in a THF/sat. NaHCO 3 (50 mL, 1:1 v/v) and cooled to 0 °C. Then allylchloro formate (2.13 mL, 20.0 mmol) was added dropwise and the mixture was stirred at this temperature for 10 min before the ice bath was removed and the reaction was allowed to stir at rt for 15 h. The reaction mixture was diluted with H 2 O (50 mL), then washed with Et 2 O (25 mL). Subsequently, HCl (5M) was added dropwise to reach pH = 1.5. The reaction mixture was extracted with ethyl acetate (3 × 100 mL), the combined organic extracts were dried over anhydrous Na 2 SO 4 , and the solvent was removed in vacuo yielding 2.60g (64%) of the desired Alloc-protected amino acid as a colorless syrup which was used in the next step without further purification.
Alloc-Thr-O t
Bu (6)
A mixture of DIC (6.20 mL, 61.0 mmol), CuCl (226 mg, 2.28 mmol) and tert-BuOH (5.0 mL) was stirred at rt under the exclusion of light for 5 d. After dilution of the mixture with CH 2 Cl 2 (25 mL), a solution of Alloc-Thr-OH (2.40 g, 11.8 mmol) in CH 2 Cl 2 (15 mL) was added dropwise and the mixture was stirred at rt for 15 h. The mixture was filtered, washed with sat. NaHCO 3 (2 ×25 mL), and the organic phase was dried over anhydrous Na 2 SO 4 .
After 
O-((R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-2-phenylacetyl)-N-((allyloxy)carbonyl)-L-threonine (4)
To a stirred solution of Alloc-Thr-O 5, 170.7, 160.9, 158.7, 145.3, 142.7, 135.4, 134.1, 130.1, 129.9, 129.6, 128.8, 128.2, 126.0, 121.0, 117.8, 73.1, 69.0, 66.9, 63.8, 58.8, 48.5, 31.7, 17 .1 ppm. 
MS (ESI+)
:
Norfijimyin A (3)
Fmoc-Ala-OH (9.34 mg, 30 µmol) and DIPEA (10.5 µL, 60 µmol) were dissolved in anhydrous CH 2 Cl 2 (0.3 mL) and added to pre-swollen 2CTC-resin (12.5 mg). After 16 h the loading mixture was dicharged from the fritted syringe and the resin was washed with CH 2 Cl 2 (5 × 1 mL), DMF (5 × 1 mL), and CH 2 Cl 2 (5 × 1 mL). Then the resin was capped according to general procedure 1 and washed with CH 2 Cl 2 (5 × 1 mL) and DMF (5 × 1 mL).
After deprotection of the first amino acid (Ala) according to general procedure 2 the resin loading was determined to be 0. Then, Alloc-protecting group was removed and the resin was washed according to general procedure 3 followed by coupling with 3-allyloxypicolinic acid (12) according to general procedure 2.
O-allyl protecting group was cleaved off according to general procedure 4 followed by cleavage of the peptide from the solid-support accordig to general procedure 2.
10% Palladium on activated charcoal (12.8 mg, 12 µmol, 50 mol-%) was added to the a solution of the N-terminal protected crude linear depsipeptide in Methanol (5 mL). The mixture was degassed by bubbling a stream of N 2 into the solution. Then, a hydrogen-filled balloon was attached and the reaction mixture was stirred at rt for 12 h before it was filtered using a PTFE-syringe filter (0.22 µm pore size). The filter was thoroughly washed with MeOH (20 mL) and the solvent was removed by a stream of N 2 .
The crude linear depsipeptide 13 was purified by reversed-phase preparative HPLC c Aliquots were taken at 2, 5, 18 and 24 h and analyzed by LC/MS: After 2 h reaction time a small amount of the linear depsipeptide was cyclized and only one diastereomer (t R = 5.05 min) was formed, presumably Norfijimycin A (3). After 5 h reaction time the amount of cyclic peptide was increased whereas a small amount of a second diastereomer (t R = 4.83 min), presumably epi-3, was also detected. The final 1:1 ratio of 3 and epi-3 was reached after 18 h. It is proposed that prolonged reaction time in the presence of coupling reagents led to increased epimerization. 
Antimicrobial Screening: Resazurin Assay for Mtb
The compounds were originally stored as 10 mM stock solutions in 100% DMSO. Two fold serial dilutions of the compounds were made in a 96 well plate using Middlebrook 7H9 medium supplemented with ADC (0.5% v/v glycerol and 0.05% v/v Tween-80).
M. tuberculosis
H37Rv was grown to mid-exponential phase to an OD 600 of 0.6-0.8 in 7H9 media at 37 °C. On the day of the assay, culture was diluted to an OD 600 of 0.002 and 100 l of bacterial suspension was added to the 96 well plate containing 100 L of the diluted compounds. The plate was incubated for 5 days at 37 °C in a humidified incubator and 30 µL of Resazurin (0.02% w/v) and 12.5 L of Tween-80 was added to each well and incubated for further 24 h. On day 6, the fluorescence was read using a BMG Labtech 
